Next Article in Journal
Point-of-Care Diagnostics for Improving Maternal Health in South Africa
Next Article in Special Issue
Dynamic Contrast-Enhanced CT in Patients with Pancreatic Cancer
Previous Article in Journal
Sternocostoclavicular Hyperostosis: An Ill-Recognized Disease
Previous Article in Special Issue
Potential Pitfalls on the 99mTc-Mebrofenin Hepatobiliary Scintigraphy in a Patient with Biliary Atresia Splenic Malformation Syndrome

18F-FET-PET in Primary Hyperparathyroidism: A Pilot Study

Department of Clinical Physiology and Nuclear Medicine, Gentofte Hospital, DK-2900 Hellerup, Denmark
Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, DK-2100 Copenhagen, Denmark
Department of Endocrinology, Herlev Hospital, DK-2730 Herlev, Denmark
Author to whom correspondence should be addressed.
Academic Editor: Gary Cook
Diagnostics 2016, 6(3), 30;
Received: 27 June 2016 / Revised: 9 August 2016 / Accepted: 11 August 2016 / Published: 17 August 2016
(This article belongs to the Collection Hybrid Imaging in Medicine)
Preoperative localisation of the diseased parathyroid gland(s) in primary hyperparathyroidism (PHP) is a prerequisite for subsequent minimally invasive surgery. Recently, as alternatives to conventional sestamibi parathyroid scintigraphy, the 11C-based positron emission tomography (PET) tracers methionine and choline have shown promise for this purpose. We evaluated the feasibility of using the 18F-based PET tracer fluoroethyl-l-tyrosine (FET), as the longer half-life of 18F makes it logistically more favourable. As a proof-of-concept study, we included two patients with PHP in which dual-isotope parathyroid subtraction single photon emission computed tomography had determined the exact location of the parathyroid adenoma. A dynamic FET PET/CT scan was performed with subsequent visual evaluation and calculation of target-to-background (TBR; parathyroid vs. thyroid). The maximum TBR in the two patients under study was achieved approximately 30 min after the injection of the tracer and was 1.5 and 1.7, respectively. This ratio was too small to allow for confident visualisation of the adenomas. FET PET/CT seems not feasible as a preoperative imaging modality in PHP. View Full-Text
Keywords: primary hyperparathyroidism; positron-emission tomography; (18F)fluoroethyl-l-tyrosine primary hyperparathyroidism; positron-emission tomography; (18F)fluoroethyl-l-tyrosine
Show Figures

Figure 1

MDPI and ACS Style

Krakauer, M.; Kjaer, A.; Bennedbæk, F.N. 18F-FET-PET in Primary Hyperparathyroidism: A Pilot Study. Diagnostics 2016, 6, 30.

AMA Style

Krakauer M, Kjaer A, Bennedbæk FN. 18F-FET-PET in Primary Hyperparathyroidism: A Pilot Study. Diagnostics. 2016; 6(3):30.

Chicago/Turabian Style

Krakauer, Martin, Andreas Kjaer, and Finn N. Bennedbæk. 2016. "18F-FET-PET in Primary Hyperparathyroidism: A Pilot Study" Diagnostics 6, no. 3: 30.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop